Ryclora (dexchlorpheniramine maleate) NDC 15370-150

NDC codes

FDA NDC Directory

Product NDC (as listed)15370-150Labeler and product segments. Claims need a package NDC.

Product NDC at billing width15370-0150Add the package segment from the table below.

Package NDCs as listed with the FDA, and the 11-digit 5-4-2 form used on claims. The highlighted digit is the added leading zero.
Package NDC	11-digit (billing)	Package
15370-150-04	15370015004	118 mL in 1 BOTTLE, PLASTIC (15370-150-04)Marketed from Oct 7, 2018
15370-150-16	15370015016	473 mL in 1 BOTTLE, PLASTIC (15370-150-16)Marketed from Oct 7, 2018
15370-150-99	15370015099	20 mL in 1 BOTTLE, PLASTIC (15370-150-99)Marketed from Oct 7, 2018

How the 11-digit form is made: The product segment has 3 digits, so one leading zero is added to it (5-3-2 → 5-4-2). Formatting the NDC does not by itself make it billable — the product, package and quantity must match what was dispensed or administered, and payer rules apply. Conversion rules

Product information

Brand name (proprietary): Ryclora
Generic name (nonproprietary): dexchlorpheniramine maleate
Active ingredients: Dexchlorpheniramine maleate — 2 mg/5mL
Dosage form: Liquid
Route: Oral
Labeler: CARWIN PHARMACEUTICAL ASSOCIATES, LLC
Product type: Prescription drug
Marketing category: ANDA — Abbreviated New Drug Application (generic)Application ANDA 202520
Marketing start: Oct 7, 2018
Listing expires: Dec 31, 2026
Identifiers: Product ID 15370-150_3affdd03-252d-443c-9966-e3aec314fb98SPL ID 3affdd03-252d-443c-9966-e3aec314fb98SPL set ID aa4f80c9-e600-4bc0-8528-02a8162a36f0RxCUI 2183907, 2183912UNII B10YD955QWUPC 0315370150164

Billing references

What Med-Code can say about coding this product, and where each statement comes from. Nothing here is inferred from the name alone.

HCPCS codeNo match

No HCPCS code in Med-Code's directory. Oral products like this are usually dispensed by a pharmacy and billed by NDC.

NDC on a medical claim

N415370015004 followed by a unit qualifier and the quantity

Package 15370-0150-04. Unit qualifiers: F2 (international unit), GR (gram), ME (milligram), ML (milliliter), UN (unit (each)). The qualifier and quantity depend on what was given. About the N4 qualifier

Product label

Current FDA label (SPL), effective Jan 8, 2024.

Indications (excerpt from the label)

INDICATIONS AND USAGE Perennial and seasonal allergic rhinitis Vasomotor rhinitis Allergic conjunctivitis due to inhalant allergens and foods Mild, uncomplicated allergic skin manifestations of urticaria and angioedema Amelioration of allergic reactions to blood or plasma Dermographism As therapy for anaphylactic reactions adjunctive to epinephrine and other standard measures after the acute manifestations have been controlled.

Excerpt only. Read the full label for complete information.

Full label on DailyMed (opens in a new tab)

Other NDCs under ANDA 202520

Products listed under the same FDA application: other strengths and forms, and repackagers who relabel the same product.

FDA NDC Directory listings under ANDA 202520
Product	Strength	Form · route	Labeler	Product NDC
Corphenadexchlorpheniramine maleate	Dexchlorpheniramine maleate 2 mg/5mL	SolutionOral	BluCrest Pharmaceuticals LLC	73684-300